Ever­est climbs clos­er to Covid-19 boost­er mar­ket; A French up­start snags funds to find drugs

Ever­est Med­i­cines said its Covid-19 mes­sen­ger RNA part­ner passed a mid-stage test in­ves­ti­gat­ing its vac­cine against Pfiz­er and BioN­Tech’s Comir­naty.

Prov­i­dence Ther­a­peu­tics’ PTX-COVID19-B

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER